# Prasugrel Or Ticagrelor De-escalation in NSTE-ACS

> **NCT05779059** · PHASE3 · UNKNOWN · sponsor: **Collegium Medicum w Bydgoszczy** · enrollment: 50 (estimated)

## Conditions studied

- Non ST Segment Elevation Acute Coronary Syndrome
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
- Unstable Angina

## Interventions

- **DRUG:** De-escalation to ticagrelor 60 mg at day 30
- **DRUG:** De-escalation to prasugrel 5 mg at day 30
- **DRUG:** Switch to ticagrelor 60 mg at day 45
- **DRUG:** Switch to prasugrel 5 mg at day 45

## Key facts

- **NCT ID:** NCT05779059
- **Lead sponsor:** Collegium Medicum w Bydgoszczy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779059, "Prasugrel Or Ticagrelor De-escalation in NSTE-ACS". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05779059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*